The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so maybe that's a critical patient if you for whatever reason want to give a statin to a really young fh or homozygous it might as master all be mine so here's what we know so when people with these cognitive and mild cognitive impairment or various dimensions have low cholesterol when you wind the bullet up see in their brains they do have low des nostril than their cerebral spinal fluid suggesting that they do part
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
which would lead simply to the hypothesis that Serum desmo is a usable biomarker to say is somebody at risk for Alzheimer's disease
epidemiologic study where they correlated low desol with serum desol people who had low serum desmal had a much higher incidence of cognitive impairment and Alzheimer's disease